Nicole Kuchinsky
Nicole Kuchinsky is responsible for internal commercial operations and industry engagement at CCRM. A strong grounding in academic research helps her to understand the science behind new technologies in cell and gene therapy that CCRM is working to commercialize. Dr. Kuchinsky obtained her Master’s degree from the University of Toronto (U of T) in the Department of Zoology and continued graduate studies at U of T in the Department of Cell and Systems Biology, where she completed a PhD in developmental neurobiology under the supervision of Dr. Vince Tropepe. Dr. Kuchinsky went on to pursue studies in translational science with Dr. Michael Fehlings at the Krembil Research Institute in Toronto. Her post-doctoral work focused on animal models of spinal cord injury and cell based therapy for spinal cord regeneration. Nicole’s interest in science communication started early, with an undergraduate double major in English and Biology from Wilfrid Laurier University. Now she focuses her writing on anything and everything related to regenerative medicine technology. Follow Nicole on Twitter @DrNKuchinsky.
Posts by: Nicole
Three tips for navigating a career transition from academia to industry
I spent over a decade (12.5 years to be exact) getting university degrees in life sciences. Let’s also not forget the 4.5 years I spent as a post-doctoral fellow. All told, I have 17 years of experience as an academic trainee. When I finally decided to make the jump from academia to industry, I was […]
RMConnectTO: Building networks to advance regenerative medicine
Most people will tell you they hate networking. No matter how much we might dread awkward chit chat, networking and relationship building are key contributors to success, regardless of industry or job title. Because commercializing regenerative medicine (RM) technologies depends on collaboration across diverse sectors, relationship building is critical. With this in mind, RMConnectTO was […]
Learning about industry from the insiders at Phacilitate Cell and Gene Therapy World 2017
In January, I attended Phacilitate’s Cell and Gene Therapy World in Miami, Florida. At this meeting industry leaders from around the world gather to discuss manufacturing, regulation and adoption of cell and gene therapies (C>). This was my first industry-focused conference, and it was a great chance to learn the ropes from experienced players in […]
Inaugural Medicine by Design Symposium – Engineering progress in regenerative medicine
On November 28 local and international leaders of the regenerative medicine (RM) community gathered at the MaRS Centre in Toronto for the first ever Medicine by Design (MbD) Symposium. The event marked the first year of the MbD program at the University of Toronto (U of T). This initiative was established based on a $114 […]
Second skin: A regenerative medicine approach to treating genetic skin diseases
One of my personal highlights from this year’s Till and McCulloch Meetings was attending the “Science for Citizens” panel (reported on in a previous post). Experts including Timothy Caulfield, patient advocate William Brock, and National Post writer Tom Blackwell emphasized the dangers of “fake news” in science and health care. I left that panel […]